Stocks with the biggest gains at noon: SOFI, CAT, SIRI, BA | Wilnesh News
Here’s a look at the companies making headlines in midday trading: SoFi Technologies – Shares of the online personal finance company jumped 9.8% after SoFi announced a $2 billion deal with Fortress Investment Group to grow its lending platform business. Sirius XM Holdings — Shares of the audio entertainment company rose more than 8% after Warren Buffett’s Berkshire Hathaway disclosed an increase in its stake in the company. Berkshire bought about 3.6 million Sirius shares last week, bringing its total holding to more than 108 million shares, according to a securities filing. Crypto Stocks – Cryptocurrency-related stocks soared as Bitcoin rose more than 5% to $66,000. Mara Holdings and Coinbase extended gains from the previous session, rising more than 4% and 7% respectively. AppLovin — Technology stocks fell 1% after Goldman Sachs downgraded its rating to neutral from buy. Goldman Sachs said AppLovin’s risk-reward ratio is more balanced after the stock’s recent outperformance. Boeing – Shares of Boeing fell 1% Friday afternoon after the plane maker announced plans to cut about 10% of its workforce, or about 17,000 jobs. Boeing also said it was delaying deliveries of its yet-to-be-certified 777X wide-body jets and expected a bigger-than-expected third-quarter loss as it continues to face losses amid an ongoing machinists’ strike. Ibotta — Ibotta, a mobile platform that offers cash back rewards, rose 5.5% after Goldman Sachs upgraded the stock to neutral buy. The bank said the company has attractive growth opportunities, such as through partnerships with Walmart and Instacart. Flutter Entertainment — The online gaming stock rose 4% after Wells Fargo upgraded shares to overweight from equal weight, urging investors to buy dips. Bank of America also restored its rating on FanDuel’s parent company, giving it a buy rating. Caterpillar — The industrial stock fell 1.7% after Morgan Stanley downgraded the stock to underweight from equal weight. The investment firm noted that there could be a backdrop of inventory drawdowns and negative risk/reward going forward. Hims & Hers Health — Shares of Hims & Hers Health rose 6.8% after the U.S. Food and Drug Administration said it will allow compounding pharmacies to sell Eli Lilly & Co.’s weight loss drug Mounjaro. —CNBC’s Alex Harring, Brian Evans, Samantha Subin, Yun Li, Lisa Kailai Han, Pia Singh and Michelle Fox contributed reporting.